| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4d6f3ebb893d12bf039c9f0ceb4cec5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2001-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f207eec2fcf581406d75e38cdceb0f56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059274dff666097482dcceff3c5f9be4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a3d76ed8a8da192ccc0d0f1896ac6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee7ba143a20a67a8cd06f8969d1937f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47cbcd587674a705d0cd68652df09624 |
| publicationDate |
2002-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2418946-A1 |
| titleOfInvention |
Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter |
| abstract |
The invention concerns a pharmaceutical form comprising a support material a nd at least a cell regulating factor and/or a cell proliferation promoter, preferably a growth factor. The invention is characterised in that the suppo rt material consists, for at least 90 wt. % of a composition based on methylide ne malonate containing: 0 to 10 wt. % of one or several methylidene malonate of formula (I) wherein: A and B independently represent a group (a) or (b) wherein R1 and R2 independently represent a C1-C6 linear or branched alkyl group, and n is an integer ranging between 1 and 5; 10 to 90 wt. %, preferab ly 50 to 90 wt. % of one or several methylidene malonate oligomer(s) having a molecular weight not more than 6000 and consisting of repeat units of formul a (II) wherein A and B are such as defined above; 10 to 90 wt. %, preferably 1 0 to 50 wt. % of one or several methylidene malonate polymer(s) having a molecular weight more than 6000 and consisting of repeat units of formula (II). Said pharmaceutical form is useful for treating skin lesions. |
| priorityDate |
2000-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |